Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
Public ClinicalTrials.gov record NCT07286214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Each of Two Dose Levels of Sarilumab in Adults With Early Polymyalgia Rheumatica
Study identification
- NCT ID
- NCT07286214
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Sarilumab Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2026
- Primary completion
- Jun 3, 2029
- Completion
- Jul 15, 2029
- Last update posted
- May 18, 2026
2026 – 2029
United States locations
- U.S. sites
- 5
- U.S. states
- 2
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Denver Arthritis Clinic - Lowry- Site Number : 8400001 | Denver | Colorado | 80230 | Recruiting |
| Clinical Research of West Florida - Phase I Unit- Site Number : 8400024 | Clearwater | Florida | 33765 | Recruiting |
| Vitalia Medical Research - Margate- Site Number : 8400021 | Margate | Florida | 33063 | Recruiting |
| Innovia Research Center- Site Number : 8400029 | Miramar | Florida | 33027 | Recruiting |
| Vantage Clinical Trials - Tampa- Site Number : 8400064 | Tampa | Florida | 33614 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07286214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07286214 live on ClinicalTrials.gov.